Aimei Health Technology Co Ltd Financials
This page shows Aimei Health Technology Co Ltd (AFJK) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Reported profit is not funding the business; liquidity collapsed as cash and assets shrank while liabilities still outweighed assets.
Across FY2024-FY2025, net income stayed positive while operating income and operating cash flow stayed negative in both years. Because cash also slid from$28K to$3K , that profit appears to be driven more by non-operating or non-cash items than by the business converting activity into cash and replenishing liquidity.
Near-term liquidity tightened sharply: FY2025 cash of
The balance sheet is shrinking faster than it is healing: assets fell to
Financial Health Signals
Aimei Health Technology Co Ltd does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Aimei Health Technology Co Ltd passes 2 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
For every $1 of reported earnings, Aimei Health Technology Co Ltd used $0.53 of operating cash (-$565K OCF vs $1.1M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.
Key Financial Metrics
Earnings & Revenue
Aimei Health Technology Co Ltd reported $1.1M in net income in fiscal year 2025. This represents a decrease of 58.5% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Cash & Balance Sheet
Aimei Health Technology Co Ltd held $3K in cash as of fiscal year 2025; long-term debt is not reported for that period.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
None of these metrics is reported for fiscal year 2025.
Capital Allocation
None of these metrics is reported for fiscal year 2025.
AFJK Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Operating Income | N/A | -$836K+21.5% | -$1.1M | N/A |
| Income Tax | N/A | $0 | $0 | $0 |
| Net Income | N/A | $1.1M-58.5% | $2.6M | N/A |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Interest Expense, EPS (Diluted).
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
AFJK Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 |
|---|---|---|---|
| Total Assets | $12.1M-83.6% | $73.8M+4.7% | $70.5M |
| Current Assets | $3K-90.4% | $30K-94.8% | $581K |
| Cash & Equivalents | $3K-89.6% | $28K-95.1% | $581K |
| Total Liabilities | $16.2M-78.5% | $75.3M+6.6% | $70.6M |
| Current Liabilities | $3.4M+312.7% | $817K+3188.9% | $25K |
| Total Equity | -$4.1M-174.9% | -$1.5M-1000.9% | -$134K |
| Retained Earnings | -$4.1M-174.8% | -$1.5M-999.3% | -$134K |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
AFJK Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Operating Cash Flow | -$371K | -$565K+15.9% | -$672K | N/A |
| Investing Cash Flow | $33.1M | N/A | -$278K | N/A |
| Financing Cash Flow | -$32.7M | N/A | $397K | N/A |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
AFJK Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 |
|---|---|---|---|
| Return on Assets | 8.8%+5.3pp | 3.5% | N/A |
| Current Ratio | 0.000.0x | 0.04-23.3x | 23.38 |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Debt-to-Equity, FCF Margin.
Note: Shareholder equity is negative (-$4.1M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.00), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Where Aimei Health Technology Co Ltd Ranks
Frequently Asked Questions
Is Aimei Health Technology Co Ltd profitable?
Yes, Aimei Health Technology Co Ltd (AFJK) reported a net income of $1.1M in fiscal year 2025.
What is Aimei Health Technology Co Ltd's operating cash flow?
Aimei Health Technology Co Ltd (AFJK) recorded an outflow of $565K in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Aimei Health Technology Co Ltd's total assets?
Aimei Health Technology Co Ltd (AFJK) had $12.1M in total assets as of fiscal year 2025, including both current and long-term assets.
What is Aimei Health Technology Co Ltd's current ratio?
Aimei Health Technology Co Ltd (AFJK) had a current ratio of 0.00 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Aimei Health Technology Co Ltd's return on assets (ROA)?
Aimei Health Technology Co Ltd (AFJK) had a return on assets of 8.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Aimei Health Technology Co Ltd's cash runway?
Based on fiscal year 2025 data, Aimei Health Technology Co Ltd (AFJK) had $3K in cash against an annual operating cash burn of $565K. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Aimei Health Technology Co Ltd's debt-to-equity ratio negative or not reported?
Aimei Health Technology Co Ltd (AFJK) has negative shareholder equity of -$4.1M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Aimei Health Technology Co Ltd's Piotroski F-Score?
Aimei Health Technology Co Ltd (AFJK) has a Piotroski F-Score of 2 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Aimei Health Technology Co Ltd's earnings high quality?
For every $1 of reported earnings, Aimei Health Technology Co Ltd (AFJK) used $0.53 of operating cash (-$565K OCF vs $1.1M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.